Oncolytics Biotech, Inc. (ONCY)
1.07
-0.03
(-2.73%)
USD |
NASDAQ |
Apr 16, 15:36
Oncolytics Biotech Shareholders Equity (Quarterly) : -3.799M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 581.33M |
| Edesa Biotech, Inc. | 13.95M |
| Lexaria Bioscience Corp. | 6.602M |
| Xenon Pharmaceuticals, Inc. | 581.76M |
| ProMIS Neurosciences, Inc. | -1.259M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.582M |
| Total Liabilities (Quarterly) | 11.38M |
| Debt to Equity Ratio | -0.1482 |
| Current Ratio | 1.122 |
| Net Debt Paydown Yield | 0.05% |